Bulletin
Investor Alert

Oncolytics Biotech Inc.

TSE: CA:ONC

GO

ONC
/zigman2/quotes/203812837/delayed

$

2.48

Change

0.00 0.00%

Volume

Volume 20,982

Feb 3, 2023, 4:00 p.m.

Quotes are delayed by 15 min

/zigman2/quotes/203812837/delayed

Previous close

$ 2.48

$ 2.48

Change

0.00 0.00%

Day low

Day high

$2.42

$2.49

Open
Open: 2.46

52 week low

52 week high

$1.06

$3.10

Open

Market cap

$146.39M

Average volume

74,265

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-0.42

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/ca/onc

MarketWatch News on ONC

  1. Oncolytics shares rise on data from Reolysin study

    9:36 a.m. April 17, 2007

    - Gabriel Madway

  2. Oncolytics Biotech gets U.K. approval for Reolysin trial

    10:45 a.m. Jan. 3, 2007

    - Gabriel Madway

  3. Oncolytics Biotech gets U.K. approval for Reolysin trial

    10:37 a.m. Jan. 3, 2007

    - Gabriel Madway

  4. Oncolytics Biotech shares up 4.3% at $2.18

    10:38 a.m. Jan. 3, 2007

    - Gabriel Madway

  5. Oncolytics starts patient enrollment in Reolysin trial

    10:59 a.m. Dec. 22, 2006

    - Gabriel Madway

  6. Oncolytics starts patient enrollment in Reolysin trial

    10:50 a.m. Dec. 22, 2006

    - Gabriel Madway

/news/nonmarketwatch/company/ca/onc

Other News on ONC

  1. Espirito Santo's Surprise Loan Move

    9:14 p.m. Jan. 30, 2011

    - The Wall Street Journal Interactive Edition

  2. Consumer, Tech Stocks Weigh on Small-Caps

    9:24 p.m. Nov. 18, 2009

    - The Wall Street Journal Interactive Edition

  3. Pinnacle Airlines Gains Altitude

    12:01 a.m. Dec. 23, 2006

    - The Wall Street Journal Interactive Edition

/news/pressrelease/company/ca/onc

Press Releases on ONC

  1. Optimism Building for Advancing Pancreatic Cancer Treatment Therapies

    8:31 a.m. Dec. 1, 2022

    - Financial News Media

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.